Globe Life Inc. (GL) Stock Price & Analysis
Globe Life Inc. (GL) closed at USD 168.41 on Thursday, October 22, 2026, down 0.71% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 169.62; the Oct 22, 2026 session ranged USD 161.52–168.56 on volume of 1,736,073 shares. Market capitalization is $12.94B, with a 52-week range of USD 127.85–191.55 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:25 UTC.
Also available as compact Markdown for AI agents: nexqual.com/GL.md
Key facts (GL)
- Last four reported quarters (through Jun 30, 2026): revenue $6.19B, net income $1.21B (19.6% margin), free cash flow $1.23B (SEC filings).
- Valuation: P/E 10.7x (avg 10.4x at the last 3 fiscal year-ends), net debt $2.49B.
- 2 of 80 tracked superinvestors hold GL (13F, Q2 2026): 0 new, 1 added, 1 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 23 Form 4 filings, $60.8M; 23 not under a Rule 10b5-1 plan ($60.8M); 15 by opportunistic insiders (15 outside 10b5-1 plans), 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 1.91 on a 1–5 scale) (11 analysts), mean target USD 192.09 (range 166–215).
- Total return with dividends: 1Y +25.1% vs S&P 500 +14.9%; 5Y +88.4% vs S&P 500 +80.3%.
- Next earnings: 2026-10-21, EPS estimate USD 3.76, revenue estimate $1.64B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (GL)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $5.11B | $5.23B | $5.45B | $5.78B | $5.99B | $6.19B |
| Gross profit | $1.22B | $1.18B | $1.26B | — | — | — |
| Operating income | $1.23B | $1.19B | $1.27B | — | — | — |
| Net income | $1.03B | $894M | $971M | $1.07B | $1.16B | $1.21B |
| EPS (diluted) | $9.99 | $9.04 | $10.07 | $11.94 | $14.07 | — |
| Free cash flow | $1.40B | $1.39B | $1.43B | $1.33B | $1.25B | $1.23B |
| Gross margin | 23.8% | 22.6% | 23.1% | — | — | — |
| Operating margin | 24.0% | 22.7% | 23.2% | — | — | — |
| Net margin | 20.2% | 17.1% | 17.8% | 18.5% | 19.4% | 19.6% |
| Revenue growth | +7.9% | +2.2% | +4.2% | +6.1% | +3.7% | — |
| Cash + short-term investments | $161M | $207M | $185M | $250M | $459M | — |
| Total debt | $1.70B | $1.79B | $1.63B | $2.74B | $2.63B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (GL)
P/E 10.7x · P/S 2.1x · EV/Sales 2.5x · P/FCF 10.5x · P/B 2.1x · FCF yield 9.52% · Earnings yield 9.37% · Dividend yield (paid, TTM) 0.70% · Buyback yield (TTM) 6.81% · Net debt $2.49B · EV $15.4B
P/E at fiscal year-ends: Dec 2025 9.9x, Dec 2024 9.3x, Dec 2023 12.1x.
Superinvestors (SEC 13F-HR, Q2 2026) (GL)
2 of 80 tracked investors hold GL. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Richard Pzena | Pzena Investment Management | 0.71% | $242M | Added +32.1% |
| Tweedy Browne | 0.30% | $4.0M | Reduced -19.6% |
Insider sales (SEC Form 4, open-market, last ~7 months) (GL)
0 of 23 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-09-22 | Hensley Robert Edward | EVP & Chief Investment Officer | 10,000 | $1.7M | 44.7% | No | Too little history (no open-market trades in 2023) |
| 2026-08-07 | Mitchell Robert Brian | EVP, General Counsel and CRO | 23,000 | $4.2M | 25.9% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-07-31 | Darden James Matthew | Co-Chairman & CEO | 50,000 | $9.1M | 44.4% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-07-30 | Kalmbach Thomas Peter | EVP & CFO | 21,000 | $3.8M | 28.9% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-07-29 | Majors Michael Clay | EVP - Chief Strategy Officer | 37,000 | $6.6M | 40.9% | No | Too little history (no open-market trades in 2024) |
| 2026-07-28 | Kalmbach Thomas Peter | EVP & CFO | 25,650 | $4.6M | 33.1% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-06-30 | Skarjune Dolores L | EVP and Chief Admin. Officer | 1,850 | $331K | 10% | No | Too little history (no open-market trades in 2024) |
| 2026-06-25 | Alston Cheryl | Director | 8,258 | $1.5M | 33.2% | No | Too little history (no open-market trades in 2024 or 2025) |
| 2026-06-18 | Zorn Rebecca E | EVP & Chief Talent Officer | 2,000 | $340K | 10.1% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-06-12 | Skarjune Dolores L | EVP and Chief Admin. Officer | 4,175 | $694K | 20.1% | No | Too little history (no open-market trades in 2024) |
| 2026-06-11…2026-06-12 | Svoboda Frank M | Co-Chairman & CEO | 20,000 | $3.3M | 9.5% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-29 | Mitchell Robert Brian | EVP, General Counsel and CRO | 600 | $93K | 0.9% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-22 | Kalmbach Thomas Peter | EVP & CFO | 7,936 | $1.2M | 13.3% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-22 | Svoboda Frank M | Co-Chairman & CEO | 20,000 | $3.1M | 9.5% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-19 | Kalmbach Thomas Peter | EVP & CFO | 11,903 | $1.9M | 19.4% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-08…2026-05-11 | Kalmbach Thomas Peter | EVP & CFO | 27,427 | $4.2M | 37.1% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-06 | Henrie Michael Shane | SVP & Chief Accounting Officer | 2,150 | $334K | 37.3% | No | Too little history (no open-market trades in 2024) |
| 2026-05-04…2026-05-05 | Svoboda Frank M | Co-Chairman & CEO | 15,000 | $2.3M | 7.3% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-05 | Darden James Matthew | Co-Chairman & CEO | 22,019 | $3.4M | 26% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
| 2026-05-01 | Svoboda Frank M | Co-Chairman & CEO | 10,000 | $1.5M | 5% | No | Opportunistic (traded every year 2023–2025, no repeating month) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Analysts (GL)
Consensus Buy (mean 1.91 on a 1–5 scale), 11 analysts; mean target USD 192.09 (low 166, high 215).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-15 | JP Morgan | Target raised | Overweight | $193 → $195 |
| 2026-10-12 | Wells Fargo | Target raised | Overweight | $190 → $191 |
| 2026-10-05 | Morgan Stanley | Target lowered | Overweight | $208 → $197 |
| 2026-07-24 | Keefe, Bruyette & Woods | Target lowered | Outperform | $192 → $190 |
| 2026-07-22 | TD Cowen | Target raised | Buy | $215 → $225 |
| 2026-07-21 | JP Morgan | Target raised | Overweight | $181 → $201 |
| 2026-07-15 | Piper Sandler | Target raised | Overweight | $175 → $200 |
| 2026-07-13 | Evercore ISI Group | Target raised | In-Line | $157 → $176 |
| 2026-07-13 | Keefe, Bruyette & Woods | Target raised | Outperform | $180 → $192 |
| 2026-07-10 | Jefferies | Target raised | Hold | $147 → $166 |
| 2026-07-09 | Wells Fargo | Target raised | Overweight | $172 → $193 |
| 2026-07-06 | Morgan Stanley | Target raised | Overweight | $181 → $208 |
Total return (dividends reinvested) (GL)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +25.1% | +88.4% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +25.2% | +13.5% |
| Volatility (annualized) | 19.6% | 35.4% |
| Max drawdown | -12.0% (Aug 2026→Oct 2026) | -53.3% (Feb 2024→Apr 2024) |
GL analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $3.76 | $3.80 | -0.9% | $1.64B | 10 |
| Next quarter (ends Mar 2027) | $3.85 | $3.89 | -1.1% | $1.69B | 10 |
| Current fiscal year (ends Dec 2026) | $15.67 | $15.68 | -0.1% | $6.41B | 10 |
| Next fiscal year (ends Dec 2027) | $16.47 | $16.57 | -0.6% | $6.80B | 10 |
Key Statistics (as of October 23, 2026 at 09:25 UTC)
| Price | USD 168.41 |
|---|---|
| Change | ▼ 0.71% (down) |
| Previous Close | USD 169.62 |
| Open | USD 164.95 |
| Day Range | USD 161.52 – 168.56 |
| 52-Week Range | USD 127.85 – 191.55 |
| Volume | 1,736,073 shares |
| Market Cap | $12.94B |
| Exchange | NYQ |
Technical Analysis (GL)
Nexqual's technical model rates GL "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:25 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.76 (neutral) |
| vs SMA50 | Below (USD 170.58) |
| MACD | -0.5 (negative) |
Analyst Ratings (GL)
Wall Street analysts rate GL "Buy" based on 11 analysts, with a mean price target of USD 192.09 (range USD 166–215), per Nexqual as of October 23, 2026 at 09:25 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 11 |
| Mean Target | USD 192.09 |
| High Target | USD 215 |
| Low Target | USD 166 |
| Buy / Hold / Sell | 8 / 3 / 0 |
Earnings (GL)
| Next Earnings Date | 2026-10-21 |
|---|---|
| EPS Estimate | USD 3.76 |
| Revenue Estimate | $1.64B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 4.84 vs est 4.89 ▼ miss |
| 2026-06-30 | USD 3.61 vs est 3.68 ▼ miss |
| 2026-03-31 | USD 3.43 vs est 3.48 ▼ miss |
| 2025-12-31 | USD 3.39 vs est 3.44 ▼ miss |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financials & Fundamentals (GL)
| Total Revenue | $6.19B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +8.00% |
| Gross Margin | +33.91% |
| Operating Margin | +24.64% |
| Profit Margin | +19.58% |
| ROE | +20.94% |
| Debt / Equity | 0.56 |
| Current Ratio | 0.8 |
| Total Cash | $455.38M |
| Total Debt | $3.43B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $1.23B (19.9% of revenue) |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Financial Health Score (GL)
Nexqual rates Globe Life Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:25 UTC.
| Growth | Mixed — Revenue +3.7% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 33%, operating 30% (last 12 months) |
| Balance Sheet | Solid — $455M cash and investments vs $2.94B debt (Jun 2026, SEC) |
| Cash Flow | Strong — FCF $1.23B (last 4 quarters to Jun 2026, SEC), 20% margin |
| Efficiency | Mixed — No data |
Ownership (GL)
| Insider Ownership | +0.70% |
|---|---|
| Institutional Ownership | +87.36% |
| Shares Outstanding | 76.85M |
| Float | 76.13M |
| Short % of Float | +3.23% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Leadership (GL)
Globe Life Inc. is led by Frank Martin Svoboda, Co-Chairman & Co-CEO, per Nexqual as of October 23, 2026 at 09:25 UTC.
| Co-Chairman & Co-CEO | Frank Martin Svoboda |
|---|---|
| Co-Chairman & Co-CEO | James Matthew Darden |
| Executive VP & CFO | Thomas Peter Kalmbach |
| Executive VP & Chief Strategy Officer | Michael Clay Majors |
| Vice President of Investor Relations | Stephen Mota |
Major Backers & Investors (GL)
Notable institutional backers of Globe Life Inc. include Invesco, AIM Sector Funds (Invesco Sector Funds)-Invesco Small Cap Value Fund, Morgan Stanley, according to Nexqual as of October 23, 2026 at 09:25 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Invesco | 6.01% |
| AIM Sector Funds (Invesco Sector Funds)-Invesco Small Cap Value Fund | 3.18% |
| Morgan Stanley | 2.53% |
| AQR Capital Management, LLC | 1.97% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 12.05% |
| BlackRock | 7.19% |
| State Street | 4.86% |
| Geode Capital | 3.65% |
| Dimensional Fund Advisors | 3.11% |
| Nuveen | 1.95% |
Source: Nexqual, October 23, 2026 at 09:25 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| UNM | Unum Group | USD 93.75 | ▲ 0.04% |
| JXN | Jackson Financial Inc. | USD 133.32 | ▲ 2.42% |
| PRI | Primerica, Inc. | USD 285.72 | ▲ 0.38% |
| LNC | Lincoln National Corporation | USD 41.11 | ▲ 1.78% |
| PUK | Prudential Public Limited Compa | USD 24.01 | ▼ 1.6% |
| CNO | CNO Financial Group, Inc. | USD 55.5 | ▲ 0.16% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:25 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt